MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
Titel:
MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
Auteur:
Jilg, Stefanie Schwaab, Juliana Sockel, Katja Crodel, Carl C. Brueckl, Valeska Stegelmann, Frank Jentzsch, Madlen Sasca, Daniel Moyses, Margarete Fuhrmann, Stephan Gundel, Daniel Caduc, Madlen Teichmann, Lino L. Heidel, Florian Al-Ali, Haifa K. Petrides, Petro E.